“Nephrotic Syndrome With Sunitinib-Associated Focal Segmental Glomerulosclerosis in a Patient With Renal Carcinoma: Partial Reversibility After Dose Adjustment: Case Report”. Revista De La Sociedad Ecuatoriana De Nefrología, Diálisis Y Trasplante, vol. 13, no. 2, Aug. 2025, pp. 149-56, https://doi.org/10.56867/118.